KNSA trade ideas

compoundinterest7 Updated 

Kiniksa has activated a double bottom chart pattern that may lead the price to $27.81 that is +37.4% from current price.

gruenberger Updated 

Updated ascending trend line. General thesis still holding.

gruenberger Updated 

Hello, Please pardon my charting. I find it is best to combine TA and some DD for the best trades lately. Definitely a solid level of resistance and higher lows in the weeks leading up. Notes regarding the drug in question, Rilonacept, which addresses recurrent pericarditis. "In RHAPSODY, the primary efficacy endpoint of time-to-first adjudicated pericarditis...

xxtamedtacoxx7

rising wedge fda approval date is the 21st and has priority review i bought in and doubled my shares of dip today

shlobby

Looking to see if PDUFA pushes this past upper resistance levels. Monthly huge inverse head and shoulder pattern. This one is set to move higher.

xxtamedtacoxx7

FDA Approval the 21st for Pericarditis forming a bull pennant

Antikythera_Mechanism Updated 

Fundamental and Technical Update coming soon! (Check Below for entry harmonic pattern.)

Charlestrad3r

Announced that six COVID-19 patients treated with mavrilimumab in Italy all responded to treatment, and 3 patients were discharged within 5 days. A follow-on controlled study in Italy is planned. Shares closed the week up 43% to $17.91. - BioPharmCatalyst Breaking through the recent top will be a strong indicator for further upside movement. Hovering aorund the...

matjaz70

it is a clasical 2B trade, have problem with stop again